Stifel on Tango Therapeutics Inc. (TNGX): 'We have been consistently bullish'

April 20, 2026 12:17 PM

Stifel analyst Laura Prendergast reiterated a Buy rating and $24.00 price target on Tango Therapeutics Inc. (NASDAQ: TNGX)The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found